Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Infarct; nausea; headache; joint pain; Flu-like symptoms; Sore throat; This is a spontaneous report from a contactable consumer downloaded from a regulatory authority- CZ-CZSUKL-21003489. An 85-year-old male patient received first dose of BNT162B2 (COMIRNATY; lot number and expiry date were unknown), intramuscular on 12Mar2021 at a single dose for COVID-19 immunization. Medical history included COVID-19 in early Dec2020, no difficult course, no hospitalization, infection detected by accident after admission to the spa, no health consequences and no health problems. Concomitant medications were not reported. On 18Mar2021, the patient began to experience symptoms of nausea, headache and joint pain reported as flu-like symptoms and sore throat. On 22Mar2021, the medical condition was resolved with a district physician who started antibiotic treatment. Outcome of the events nausea, headache, joint pain, flu-like symptoms and sore throat was recovered on 22Mar2021. The patient died on 30Mar2021 and the doctor stated a heart attack resulting in death, also reported as infarct/acute myocardial infarction. An autopsy was not performed. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: Infarct myocardial
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166